Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections.

The increase in emerging drug resistant Gram-negative bacterial infections is a global concern. In addition, there is growing recognition that compromising the microbiota through the use of broad-spectrum antibiotics can impact long term patient outcomes. Therefore, there is the need to develop new...

Descrición completa

Detalles Bibliográficos

Principais autores:	Kenneth Johnson, James C Delaney, Thomas Guillard, Fany Reffuveille, Jennifer Varin-Simon, Kai Li, Andrew Wollacott, Eric Frapy, Surin Mong, Hamid Tissire, Karthik Viswanathan, Faycal Touti, Gregory J Babcock, Zachary Shriver, Bradley L Pentelute, Obadiah Plante, David Skurnik
Formato:	Artigo
Idioma:	Inglês
Publicado:	Public Library of Science (PLoS) 2023-09-01
Series:	PLoS Pathogens
Acceso en liña:	https://doi.org/10.1371/journal.ppat.1011612
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!